Table III.
Preoperative and 1-year postoperative PROMs in the 1042 patients undergoing primary shoulder arthroplasty
| Variable | All |
GHOA-rTSA |
CTA-rTSA |
GHOA-aTSA |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preoperative value | 1-yr value | 1-yr change | Preoperative value | 1-yr value | 1-yr change | Preoperative value | 1-yr value | 1-yr change | Preoperative value | 1-yr value | 1-yr change | |
|
| ||||||||||||
| PSS total | 32 (22, 42.9) | 87.5 (75, 94) | 50.1 (48.8, 51.4) | 31 (21, 43) | 88.4 (80.4, 94.6) | 53.7 (51.5, 55.9) | 30.4 (20.7, 41.1) | 77.9 (61.7, 89.3) | 42 (39.4, 44.6) | 33 (24, 44) | 91 (81, 96.5) | 52.9 (51, 54.7) |
| PSS pain | 11 (7, 15) | 28 (25, 30) | 15.5 (15, 16) | 11 (7, 15) | 29 (27, 30) | 16.5 (15.5, 17) | 11 (7, 16) | 27 (22.5, 29) | 13.5 (12.5, 14.5) | 11 (7, 15) | 28 (26, 30) | 16 (15.5, 16.5) |
| PSS function | 19 (12.6, 27) | 51.1 (42.5, 56) | 28.3 (27.5, 29.1) | 19 (11.1, 26.7) | 51.6 (45.6, 56) | 30.7 (29.3, 32.1) | 17.9 (11.2, 25.4) | 44.2 (34, 52.6) | 23.5 (21.7, 25.1) | 20 (14, 28) | 54 (47, 57.8) | 29.9 (28.6, 31) |
| PSS satisfaction | 1 (0, 3) | 9 (8, 10) | 7.5 (7, 7.5) | 1 (0, 2) | 10 (8, 10) | 7.5 (7.5, 8) | 1 (0, 3) | 9 (5, 10) | 6.5 (6, 7) | 1 (0, 3) | 10 (8, 10) | 7.5 (7, 7.5) |
| ASES total | 36.7 (23.3, 49.1) | 88.8 (76.7, 95) | 46.9 (45.6, 48.3) | 36.7 (21.8, 46.7) | 90 (82, 95) | 51 (48.5, 53.6) | 36.9 (25, 50) | 80.4 (67, 90) | 39.4 (36.8, 42) | 38 (25, 50) | 91.7 (81.3, 96.7) | 49.2 (47.3, 51.2) |
| ASES pain | 20 (10, 30) | 50 (40, 50) | 25 (25, 25) | 20 (10, 30) | 50 (45, 50) | 27.5 (25, 27.5) | 20 (10, 30) | 45 (40, 50) | 22.5 (20, 25) | 20 (10, 30) | 50 (45, 50) | 25 (25, 27.5) |
| ASES function | 15 (10, 21.7) | 41.7 (33.3, 46.3) | 23.2 (22.5, 23.9) | 14.8 (9.39, 21.7) | 41.7 (36.1, 45.8) | 24.9 (23.7, 26.2) | 14.8 (10, 20) | 35.2 (26.7, 42.6) | 18.8 (17.4, 20.2) | 16.7 (11.1, 21.7) | 43.3 (37, 46.7) | 24.8 (23.7, 25.8) |
| SANE | 30 (20, 50) | 90 (80, 95) | 55 (52.5, 55) | 30 (15, 50) | 90 (80, 98) | 57.5 (55, 60) | 30 (17.2, 50) | 80 (70, 95) | 47.5 (45, 50) | 30 (20, 50) | 90 (80, 98) | 56 (54.5, 57.5) |
| VR-12 MCS | 52.9 (43.9, 60.7) | 56.1 (47, 60.9) | 1.3 (0.7, 2) | 56 (47.2, 61.8) | 57.2 (48.9, 61.5) | 0.7 (−0.4, 1.7) | 49.3 (41.3, 58.4) | 53.6 (44.3, 60.5) | 2 (0.7, 3.4) | 52.9 (43.7, 61.1) | 56.2 (47.1, 60.6) | 1.4 (0.4, 2.3) |
| VR-12 PCS | 31.2 (25.5, 37.7) | 43.3 (34.1, 51.5) | 10.4 (9.8, 11.1) | 30.6 (25.1, 37.3) | 43.2 (35.2, 51.5) | 11.5 (10.3, 12.7) | 30.3 (24.7, 35.8) | 39 (31.2, 46.5) | 8 (6.8, 9.2) | 31.9 (26.5, 39) | 45.9 (37.3, 52.9) | 11.4 (10.5, 12.3) |
PROMs, patient-reported outcome measures; PSS, PENN Shoulder Score; ASES, American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form; SANE, Single Assessment Numeric Evaluation; VR-12, Veterans RAND 12-Item Health Survey; MCS, mental component summary; PCS, physical component summary; GHOA, glenohumeral osteoarthritis; rTSA, reverse total shoulder arthroplasty; CTA, rotator cuff tear arthropathy; aTSA, primary anatomic total shoulder arthroplasty.
Preoperative and 1-yr values are presented as medians (quartiles). 1-yr changes are presented as medians (95% confidence intervals).